Aerosol-mediated non-viral lung gene therapy: The potential of aminoglycoside-based cationic liposomes
Aerosol lung gene therapy using non-viral delivery systems represents a credible therapeutic strategy for chronic respiratory diseases, such as cystic fibrosis (CF). Progress in CF clinical setting using the lipidic formulation GL67A has demonstrated the relevance of such a strategy while emphasizin...
Hauptverfasser: | Le Gall, T, Berchel, M, Davies, L, Mottais, A, Ghanem, R, Fautrel, A, Gill, D, Hyde, S, Lehn, P, Lehn, J-M, Lemiègre, L, Benvegnu, T, Jaffrès, P-A, Pitard, B, Montier, T |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
MDPI
2021
|
Ähnliche Einträge
Ähnliche Einträge
-
Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure
von: Lindberg, MF, et al.
Veröffentlicht: (2015) -
Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex - Potential benefits for cystic fibrosis lung gene therapy
von: Mottais, A, et al.
Veröffentlicht: (2017) -
Gene therapy of cystic fibrosis: plasmid DNA contribution on in vivo lipid-based transfection efficacy
von: Lindberg, M, et al.
Veröffentlicht: (2011) -
A poly-functional gene delivery system for cystic fibrosis
von: Montier, T, et al.
Veröffentlicht: (2017) -
Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
von: Davies, L, et al.
Veröffentlicht: (2014)